Fidelity Investments
LUCD icon

Fidelity Investments’s Lucid Diagnostics LUCD Stock Holding History

Fidelity Investments’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$139K Buy
120,569
+89,611
+289% +$114K ﹤0.01% 3661
2025
Q4 		$33.7K Buy
30,958
+30,655
+10,117% +$34.3K ﹤0.01% 4269
2025
Q3 		$306 Sell
303
-856
-74% -$935 ﹤0.01% 5125
2025
Q2 		$1.33K Buy
1,159
+604
+109% +$780 ﹤0.01% 4924
2025
Q1 		$827 Buy
+555
New +$666 ﹤0.01% 4975
2022
Q3 		– Sell
-182
Closed – – 5202
2022
Q2 		$0 Buy
+182
New +$404 ﹤0.01% 5261

Other funds holding LUCD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Fidelity Investments's LUCD Position: Q1 2026 in Review

Fidelity Investments increased its Lucid Diagnostics (LUCD) stake by 289% in Q1 2026, buying an estimated $114K and bringing the position to 120,569 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #3661.

Fidelity Investments first reported a position in LUCD in Q2 2022 and has held it in 6 quarters since. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • Fidelity Investments held 120,569 shares of Lucid Diagnostics worth $139K as of Q1 2026.
  • Fidelity Investments bought 89,611 Lucid Diagnostics shares in Q1 2026, an estimated $114K.
  • Lucid Diagnostics made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #3661 holding.
  • Fidelity Investments first reported a position in Lucid Diagnostics in Q2 2022 and has held it in 6 quarters since.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.